Validation of assays for inflammatory mediators in exhaled breath condensate

European Respiratory Journal

Volumn 31, Issue 5, 2008, Pages 943-948

  Bayley, D L ^a   Abusriwil, H ^a   Ahmad, A ^a   Stockley, R A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

1 antitrypsin; Exhaled breath condensate; Interleukin 8; Leukotriene B4; Myeloperoxidase; Secretory leukoprotease inhibitor

Indexed keywords

ALPHA 1 ANTITRYPSIN; INTERLEUKIN 8; LEUKOTRIENE B4; MYELOPEROXIDASE; AUTACOID;

ADULT; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPIRED AIR; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SPIROMETRY; SPUTUM ANALYSIS; AGED; BREATH ANALYSIS; CASE CONTROL STUDY; CHEMISTRY; CHRONIC BRONCHITIS; EXHALATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPUTUM; VALIDATION STUDY;

ADULT; AGED; BREATH TESTS; BRONCHIECTASIS; BRONCHITIS, CHRONIC; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXHALATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 47049098974     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00081707     Document Type: Article

References (21)

1. Sack U, Scheibe R, Wötzel M, et al. Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 2006; 69: 169-172.
2. Montuschi P, Macagno F, Parente P, et al. Effects of cyclooxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 2005; 60: 827-833.
3. Panchaud A, Avois L, Roulet M, et al. A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes. Anal Biochem 2005; 341: 58-68.
4. Izquierdo JL, Almonacid C, Parra T, Pérez J. [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease]. Arch Bronconeumol 2006; 42: 332-337.
5. Leung TF, Li CY, Yung E, Liu EK, Lam CW, Wong GW. Clinical and technical factors affecting pH and other biomarkers in exhaled breath condensate. Pediatr Pulmonol 2006; 41: 87-94.
6. Zihlif N, Paraskakis E, Tripoli C, Lex C, Bush A. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate. Pediatr Pulmonol 2006; 41: 509-514.
7. Simpson JL, Wood LG, Gibson PG. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy 2005; 35: 1180-1185.
8. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965; 1: 775-779.
9. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.
10. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994; 88: 165-194.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
12. Stockley RA, Bayley DL. Validation of assays for inflammatory mediators in sputum. Eur Respir J 2000; 15: 778-781.
13. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
14. Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm Res 2000; 17: 1551-1557.
15. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007; 175: 222-227.
16. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58: 294-298.
17. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 1112-1119.
18. Afford SC, Stockley RA, Kramps JA, Dijkman JH, Burnett D. Concentration of bronchoalveolar lavage fluid by ultrafiltration: evidence of differential protein loss and functional inactivation of proteinase inhibitors. Anal Biochem 1985; 151: 125-130.
19. Rosias PP, Robroeks CM, Niemarkt HJ, et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur Respir J 2006; 28: 1036-1041.
20. Liu J, Conrad DH, Chow S, Tran VH, Yates DH, Thomas PS. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J 2007; 30: 807-808.
21. Campbell JK, McCann KP, Stewart PM, Stockley RA. The effect of sputum and its constituents on the expression and secretion of secretory leukoprotease inhibitor (SLPI). Eur Respir J 1998; 12: Suppl. 28, 398s.